Potential Use of Stem Cells in Neuroreplacement Therapies for Neurodegenerative Diseases

International Review of Cytology

Volumn 228, Issue , 2003, Pages 1-30

  Sugaya, Kiminobu ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Mesenchymal stem cells; Neural stem cells; Parkinson's disease

Indexed keywords

DOPAMINE;

AGING; ALZHEIMER DISEASE; BRAIN CELL; CELL DIFFERENTIATION; CELL MATURATION; CELL POPULATION; COGNITION; CYTOLOGY; DEGENERATIVE DISEASE; EMBRYO CELL; HUMAN; IMMUNOCYTOCHEMISTRY; MEDICAL RESEARCH; MESENCHYME CELL; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; SUBSTITUTION THERAPY;

ANIMALIA;

EID: 0345306695     PISSN: 00747696     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7696(03)28001-3     Document Type: Article

References (137)

1. Aleksandrova, M. A., Saburina, I. N., et al. (2002). Behavior of human neural progenitor cells transplanted to rat brain. Brain Res. Dev. Brain Res. 134(1-2), 143-148.
2. Alonso, G., Prieto, M., et al. (1999). Tangential migration of young neurons arising from the subventricular zone of adult rats is impaired by surgical lesions passing through their natural migratory pathway. J. Comp. Neurol. 405(4), 508-528.
3. Alvarez-Buylla, A., and Kirn, J. R. (1997). Birth, migration, incorporation, and death of vocal control neurons in adult songbirds. J. Neurobiol. 33(5), 585-601.
4. Ando, K., Oishi, M., et al. (1999). Role of phosphorylation of Alzheimer's amyloid precursor protein during neuronal differentiation. J. Neurosci. 19(11), 4421-4427.
5. Arai, Y., Suzuki, A., et al. (1997). Developmental and aging changes in the expression of amyloid precursor protein in Down syndrome brains. Brain Dev. 19(4), 290-294.
6. Arsenijevic, Y., Villemure, J. G., et al. (2001). Isolation of multipotent neural precursors residing in the cortex of the adult human brain. Exp. Neurol. 170(1), 48-62.
7. Bacon Moore, A. S., Paulsen, J. S., et al. (1999). A test of odor fluency in patients with Alzheimer's and Huntington's disease. J. Clin. Exp. Neuropsychol. 21(3), 341-351.
8. Bahn, S., Mimmack, M., et al. (2002). Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: A gene expression study. Lancet 359(9303), 310-315.
9. Beckman, M., Iverfeldt, K., et al. (1997). Increased gene expression of beta-amyloid precursor protein and its homologues APLP1 and APLP2 in human neuroblastoma cells in response to retinoic acid. Neurosci. Lett. 221(2-3), 73-76.
10. Bentlage, C., Nikkhah, G., et al. (1999). Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host. Exp. Neurol. 159(1), 177-190.
11. Bianco, P., Riminucci, M., et al. (2001). Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 19(3), 180-192.
12. Biglan, K., and Holloway, R. G. (2001). Initial treatment of early Parkinson's disease: A review of recent, randomized controlled trials. Curr. Neurol. Neurosci. Rep. 1(4), 329-336.
13. Bjorklund, A., and Lindvall, O. (2000). Cell replacement therapies for central nervous system disorders. Nat. Neurosci. 3(6), 537-544.
14. Bjorklund, L. M., Sanchez-Pemaute, R., et al. (2002). Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl. Acad. Sci. USA 99(4), 2344-2349.
15. Bondolfi, L., Calhoun, M., et al. (2002). Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice. J. Neurosci. 22(2), 515-522.
16. Borlongan, C. V., and Sanberg, P. R. (2002). Neural transplantation for treatment of Parkinson's disease. Drug Discov. Today 7(12), 674-682.
17. Brannen, C. L., and Sugaya, K. (2000). In vitro differentiation of multipotent human neural progenitors in serum-free medium. Neuroreport 11(5), 1123-1128.
18. Carlsson, A. (2002). Treatment of Parkinson's with L-DOPA. The early discovery phase, and a comment on current problems. J. Neural Transm. 109(5-6), 777-787.
19. Carvey, P. M., Ling, Z. D., et al. (2001). A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: A source of cells for transplantation in Parkinson's disease. Exp. Neurol. 171(1), 98-108.
20. Chen, J., Li, Y., et al. (2000). Intracerebral transplantation of bone marrow with BDNF after MCAo in rat. Neuropharmacology 39(5), 711-716.
21. Chopp, M., Zhang, X. H., et al. (2000). Spinal cord injury in rat: Treatment with bone marrow stromal cell transplantation. Neuroreport 11(13), 3001-3005.
22. Clark, R. F., Hutton, M., et al. (1996). The role of presenilin 1 in the genetics of Alzheimer's disease. Cold Spring Harb. Symp. Quant. Biol. 61, 551-558.
23. Clarkson, E. D. (2001). Fetal tissue transplantation for patients with Parkinson's disease: A database of published clinical results. Drugs Aging 18(10), 773-785.
24. Collier, T. J., Sortwell, C. E., et al. (2002). Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: Feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease. J. Comp. Neurol. 442(4), 320-330.
25. Coulson, E. J., Paliga, K., et al. (2000). What the evolution of the amyloid protein precursor supergene family tells us about its function. Neurochem. Int. 36(3), 175-184.
26. Crews, L., and Hunter, D. (1994). Neurogenesis in the olfactory epithelium. Perspect. Dev. Neurobiol. 2(2), 151-161.
27. Danisi, F. (2002). Parkinson's disease. Therapeutic strategies to improve patient function and quality of life. Geriatrics 57(3), 46-50.
28. De Strooper, B., and Annaert, W. (2000). Proteolytic processing and cell biological functions of the amyloid precursor protein. J. Cell Sci. 113(pt. 11), 1857-1870.
29. Doetsch, F., and Caille, I. (1999). Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97(6), 703-716.
30. Ducray, A., Bondier, J. R., et al. (2002). Recovery following peripheral destruction of olfactory neurons in young and adult mice. Eur. J. Neurosci. 15(12), 1907-1917.
31. Duff, K., Eckman, C., et al. (1996). Increased amyloid-beta42 (43) in brains of mice expressing mutant presenilin 1. Nature 383(6602), 710-713.
32. Ferrari, G., Cusella-De Angelis, G., et al. (1998). Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279(5356), 1528-1530.
33. Freed, C. R., Greene, P. E., et al. (2001). Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344(10), 710-719.
34. Freeman, T. B., Willing, A., et al. (2001). Neural transplantation in Parkinson's disease. Adv. Neurol. 86(14), 435-445.
35. Fricker, R. A., Carpenter, M. K., et al. (1999). Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. J. Neurosci. 19, 5990-6005.
36. Fricker-Gates, R. A., Lundberg, C., et al. (2001). Neural transplantation: Restoring complex circuitry in the striatum. Restor. Neurol. Neurosci. 19(1-2), 119-138.
37. Galli, C., Piccini, A., et al. (1998). Increased amyloidogenic secretion in cerebellar granule cells undergoing apoptosis. Proc. Natl. Acad. Sci. USA 95(3), 1247-1252.
38. Gould, E., Reeves, A. J., et al. (1999). Hippocampal neurogenesis in adult Old World primates. Proc. Natl. Acad. Sci. USA 96(9), 5263-5267.
39. Greenberg, S. M., Koo, E. H., et al. (1994). Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. Proc. Natl. Acad. Sci. USA 91(15), 7104-7108.
40. Halvorsen, Y. C., Wilkison, W. O., et al. (2000). Adipose-derived stromal cells-their utility and potential in bone formation. Int. J. Obes. Relat. Metab. Disord. 24(Suppl. 4), S41-S44.
41. Hayashi, Y., Kashiwagi, K., et al. (1994). Alzheimer amyloid protein precursor enhances proliferation of neural stem cells from fetal rat brain. Biochem. Biophys. Res. Commun. 205(1), 936-943.
42. Hoehn, M., Kustermann, E., et al. (2002). Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc. Natl. Acad. Sci. USA 99(25), 16267-16272.
43. Hoffmann, J., Twiesselmann, C., et al. (2000). A possible role for the Alzheimer amyloid precursor protein in the regulation of epidermal basal cell proliferation. Eur. J. Cell Biol. 79(12), 905-914.
44. Huang, H. M., Ou, H. C., et al. (2000). Antioxidants prevent amyloid peptide-induced apoptosis and alteration of calcium homeostasis in cultured cortical neurons. Life Sci. 66(19), 1879-1892.
45. Hugon, J., Esclaire, F., et al. (1999). Toxic neuronal apoptosis and modifications of tau and APP gene and protein expressions. Drug Metab. Rev. 31(3), 635-647.
46. Humpherys, D., Eggan, K., et al. (2001). Epigenetic instability in ES cells and cloned mice. Science 293(5527), 95-97.
47. Hung, A. Y., Koo, E. H., et al. (1992). Increased expression of beta-amyloid precursor protein during neuronal differentiation is not accompanied by secretory cleavage. Proc. Natl. Acad. Sci. USA 89(20), 9439-9443.
48. Imasawa, T., Utsunomiya, Y., et al. (2001). The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells. J. Am. Soc. Nephrol. 12(7), 1401-1409.
49. Ishiguro, M., Ohsawa, I., et al. (1998). Secreted form of beta-amyloid precursor protein activates protein kinase C and phospholipase Cgamma1 in cultured embryonic rat neocortical cells. Brain Res. Mol. Brain Res. 53(1-2), 24-32.
50. Jankovic, J. (2002). Levodopa strengths and weaknesses. Neurology 58(4 Suppl. 1), S19-32.
51. Jiang, Y., Jahagirdar, B. N., et al. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418(6893), 41-49.
52. Johansson, C. B., Momma, S., et al. (1999a). Identification of a neural stem cell in the adult mammalian central nervous system. Cell 96(1), 25-34.
53. Johansson, C. B., Svensson, M., et al. (1999b). Neural stem cells in the adult human brain. Exp. Cell Res. 253(2), 733-736.
54. Kang, Y. K., Koo, D. B., et al. (2001). Aberrant methylation of donor genome in cloned bovine embryos. Nat. Genet. 28(2), 173-177.
55. Karran, E. H., Allsop, D., et al. (1998). Presenilins-in search of functionality. Biochem. Soc. Trans. 26(3), 491-496.
56. Kawasaki, H., Suemori, H., et al. (2002). Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity. Proc. Natl. Acad. Sci. USA 99(3), 1580-1585.
57. Kim, H. M., Qu, T., et al. (2002a). Reelin function in neural stem cell biology. Proc. Natl. Acad. Sci. USA 99(6), 4020-4025.
58. Kim, J. H., Auerbach, J. M., et al. (2002b). Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418(6893), 50-56.
59. Kirazov, E., Kirazov, L., et al. (2001). Ontogenetic changes in protein level of amyloid precursor protein (APP) in growth cones and synaptosomes from rat brain and prenatal expression pattern of APP mRNA isoforms in developing rat embryo. Int. J. Dev. Neurosci. 19(3), 287-296.
60. Kopen, G. C., Prockop, D. J., et al. (1999). Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc. Natl. Acad. Sci. USA 96(19), 10711-10716.
61. Korczyn, A. D., and Nussbaum, M. (2002). Emerging therapies in the pharmacological treatment of Parkinson's disease. Drugs 62(5), 775-786.
62. Koszyca, B., Blumbergs, P. C., et al. (1998). Widespread axonal injury in gunshot wounds to the head using amyloid precursor protein as a marker. J. Neurotrauma 15(9), 675-683.
63. Kuhn, H. G., and Dickinson-Anson, H. (1996). Neurogenesis in the dentate gyrus of the adult rat: Age-related decrease of neuronal progenitor proliferation. J. Neurosci. 16(6), 2027-2033.
64. Larsson, L. C., and Widner, H. (2000). Neural tissue xenografting. Scand. J. Immunol. 52(3), 249-256.
65. LeBlanc, A. (1995). Increased production of 4 kDa amyloid beta peptide in serum deprived human primary neuron cultures: Possible involvement of apoptosis. J. Neurosci. 15(12), 7837-7846.
66. LeBlanc, A., Liu, H., et al. (1999). Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease. J. Biol. Chem. 274(33), 23426-23436.
67. Lee, S. H., Lumelsky, N., et al. (2000). Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat. Biotechnol. 18(6), 675-679.
68. Levy-Lahad, E., Wijsman, E. M., et al. (1995). A familial Alzheimer's disease locus on chromosome 1. Science 269(5226), 970-973.
69. Li, Y., Chopp, M., et al. (2000). Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J. Cereb. Blood Flow Metab. 20(9), 1311-1319.
70. Liechty, K. W., MacKenzie, T. C., et al. (2000). Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat. Med. 6(11), 1282-1286.
71. Lindvall, O. (2000). Neural transplantation in Parkinson's disease. Novartis Found. Symp. 231, 110-123.
72. Lindvall, O., and Hagell, P. (2000). Clinical observations after neural transplantation in Parkinson's disease. Prog. Brain Res. 127, 299-320.
73. Lindvall, O., and Hagell, P. (2001). Cell therapy and transplantation in Parkinson's disease. Clin. Chem. Lab. Med. 39(4), 356-361.
74. Mackenzie, T. C., and Flake, A. W. (2001). Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep. Blood Cells Mol. Dis. 27(3), 601-604.
75. Majumdar, M. K., Thiede, M. A., et al. (1998). Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J. Cell. Physiol. 176(1), 57-66.
76. Makino, S., Fukuda, K., et al. (1999). Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103(5), 697-705.
77. Martinez-Serrano, A., Hantzopoulos, P. A., et al. (1996). Ex vivo gene transfer of brain-derived neurotrophic factor to the intact rat forebrain: Neurotrophic effects on cholinergic neurons. Eur. J. Neurosci. 8(4), 727-735.
78. McNamara, M. J., Ruff, C. T., et al. (1998). Immunohistochemical and in situ analysis of amyloid precursor-like protein-1 and amyloid precursor-like protein-2 expression in Alzheimer disease and aged control brains. Brain Res. 804(1), 45-51.
79. Miyachi, T., Asai, K., et al. (2001). Interleukin-1beta induces the expression of lipocortin 1 mRNA in cultured rat cortical astrocytes. Neurosci. Res. 40(1), 53-60.
80. Modo, M., Rezaie, P., et al. (2002a). Transplantation of neural stem cells in a rat model of stroke: Assessment of short-term graft survival and acute host immunological response. Brain Res. 958(1), 70-82.
81. Modo, M., Stroemer, R. P., et al. (2002b). Effects of implantation site of stem cell grafts on behavioral recovery from stroke damage. Stroke 33(9), 2270-2278.
82. Munsie, M. J., Michalska, A. E., et al. (2000). Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei. Curr. Biol. 10(16), 989-992.
83. Murakami, N., Yamaki, T., et al. (1998). Experimental brain injury induces expression of amyloid precursor protein, which may be related to neuronal loss in the hippocampus. J. Neurotrauma 15(11), 993-1003.
84. Murphy, C. (1999). Loss of olfactory function in dementing disease. Physiol. Behav. 66(2), 177-182.
85. Murphy, C., and Jinich, S. (1996). Olfactory dysfunction in Down's syndrome. Neurobiol. Aging 17(4), 631-637.
86. Nakatomi, H., Kuriu, T., et al. (2002). Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 110(4), 429-441.
87. Ohsawa, I., Takamura, C., et al. (1999). Amino-terminal region of secreted form of amyloid precursor protein stimulates proliferation of neural stem cells. Eur. J. Neurosci. 11(6), 1907-1913.
88. Ohsawa, I., Takamura, C., et al. (2001). Fibulin-1 binds the amino-terminal head of beta-amyloid precursor protein and modulates its physiological function. J. Neurochem. 76(5), 1411-1420.
89. Olsson, M., Bentlage, C., et al. (1997). Extensive migration and target innervation by striatal precursors after grafting into the neonatal striatum. Neuroscience 79(1), 57-78.
90. Ostenfeld, T., Caldwell, M. A., et al. (2000). Human neural precursor cells express low levels of telomerase in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation. Exp. Neurol. 164(1), 215-226.
91. Pereira, R. F., Halford, K. W., et al. (1995). Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc. Natl. Acad. Sci. USA 92(11), 4857-4861.
92. Petersen, B. E., Bowen, W. C., et al. (1999). Bone marrow as a potential source of hepatic oval cells. Science 284(5417), 1168-1170.
93. Piccini, A., Ciotti, M. T., et al. (2000). Endogenous APP derivatives oppositely modulate apoptosis through an autocrine loop. Neuroreport 11(7), 1375-1379.
94. Pittenger, M. F., Mackay, A. M., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284(5411), 143-147.
95. Prockop, D. J. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276(5309), 71-74.
96. Prockop, D. J., Azizi, S. A., et al. (2000). Potential use of marrow stromal cells as therapeutic vectors for diseases of the central nervous system. Prog. Brain Res. 128(6), 293-297.
97. Qu, T., Brannen, C. L., et al. (2001). Human neural stem cells improve cognitive function of aged brain. Neuroreport 12, 1127-1132.
98. Ray, W. J., Yao, M., et al. (1999). Evidence for a physical interaction between presenilin and Notch. Proc. Natl. Acad. Sci. USA 96(6), 3263-3268.
99. Rideout, W. M., III, Eggan, K., et al. (2001). Nuclear cloning and epigenetic reprogramming of the genome. Science 293(5532), 1093-1098.
100. Riggs, A. D. (1989). DNA methylation and cell memory. Cell Biophys. 15(1-2), 1-13.
101. Roch, J. M., Jin, L. W., et al. (1993). Biologically active domain of the secreted form of the amyloid beta/A4 protein precursor. Ann. N. Y. Acad. Sci. 695, 149-157.
102. Rohn, T. T., Ivins, K. J., et al. (2000). A monoclonal antibody to amyloid precursor protein induces neuronal apoptosis. J Neurochem. 74, 2331-2342.
103. Ruiz-Arguelles, G. J., Gomez-Almaguer, D., et al. (2001). Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens. Am. J. Hematol. 66(4), 241-244.
104. Salinero, O., Moreno-Flores, M. T., et al. (2000). Increasing neurite outgrowth capacity of beta-amyloid precursor protein proteoglycan in Alzheimer's disease. J. Neurosci. Res. 60(1), 87-97.
105. Sanchez-Pernaute, R., Studer, L., et al. (2001). In vitro generation and transplantation of precursor-derived human dopamine neurons. J. Neurosci. Res. 65(4), 284-288.
106. Sanchez-Ramos, J., Song, S., et al. (2000). Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp. Neurol. 164(2), 247-256.
107. Sawa, A. (1999). Neuronal cell death in Down's syndrome. J. Neural Transm. Suppl. 57(11), 87-97.
108. Sawamoto, K., Nakao, N., et al. (2001). Generation of dopaminergic neurons in the adult brain from mesencephalic precursor cells labeled with a nestin-GFP transgene. J. Neurosci. 21, 3895-3903.
109. Schinstine, M., Iacovitti, L., et al. (1997). 5-Azacytidine and BDNF enhance the maturation of neurons derived from EGF-generated neural stem cells. Exp. Neurol. 144(2), 315-325.
110. Schuldt, A. J., Brand, A. H., et al. (1999). Mastermind acts downstream of notch to specify neuronal cell fates in the Drosophila central nervous system. Dev. Biol. 205(2), 287-295.
111. Schwarz, E. J., Alexander, G. M., et al. (1999). Multipotential marrow stromal cells transduced to produce L-DOPA: Engraftment in a rat model of Parkinson disease. Hum. Gene Ther. 10(15), 2539-2549.
112. Serby, M. (1986). Olfaction and Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 10(3-5), 579-586.
113. Shamblott, M. J., Axelman, J., et al. (2001). Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proc. Natl. Acad. Sci. USA 98(1), 113-118.
114. Sinden, J. D., Stroemer, P., et al. (2000). Functional repair with neural stem cells. Novartis Found. Symp. 231(2), 270-283.
115. Singh, G. (2001). Sources of neuronal material for implantation. Neuropathology 21(2), 110-114.
116. orbi, S., Forleo, P., et al. (1997). Alzheimer's disease: Phenotyes and genotypes. Funct. Neurol. 12(3-4), 147-151.
117. Sortwell, C. E., Camargo, M. D., et al. (2001). Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval. Exp. Neurol. 169(1), 23-29.
118. Steiner, H., Pesold, B., et al. (1999). An in vivo assay for the identification of target proteases which cleave membrane-associated substrates. FEBS Lett. 463(3), 245-249.
119. Storch, A., Paul, G., et al. (2001). Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp. Neurol. 170(2), 317-325.
120. Subramanian, T. (2001). Cell transplantation for the treatment of Parkinson's disease. Semin. Neurol. 21(1), 103-115.
121. Svendsen, C. N., ter Borg, M. G., et al. (1998). A new method for the rapid and long term growth of human neural precursor cells. J. Neurosci. Methods 85(2), 141-152.
122. Terada, N., and Hamazaki, T. (2002). Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416(6880), 542-545.
123. Toma, J. G., Akhavan, M., et al. (2001). Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat. Cell Biol. 3(9), 778-784.
124. Uchida, N., Buck, D. W., et al. (2000). Direct isolation of human central nervous system stem cells. Proc. Natl. Acad. Sci. USA 97(26), 14720-14725.
125. van Praag, H., Schinder, A. F., et al. (2002). Functional neurogenesis in the adult hippocampus. Nature 415(6875), 1030-1034.
126. von Koch, C. S., Zheng, H., et al. (1997). Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice. Neurobiol. Aging 18(6), 661-669.
127. Wallace, W. C., Akar, C. A., et al. (1997). Amyloid precursor protein requires the insulin signaling pathway for neurotrophic activity. Brain Res. Mol. Brain Res. 52(2), 213-227.
128. Wang, C., Wurtman, R. J., et al. (2000). Amyloid precursor protein and membrane phospholipids in primary cortical neurons increase with development, or after exposure to nerve growth factor or Abeta (1-40). Brain Res. 865(2), 157-167.
129. Wasco, W., Bupp, K., et al. (1992). Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor. Proc. Natl. Acad. Sci. USA 89(22), 10758-10762.
130. White, A. R., Zheng, H., et al. (1998). Survival of cultured neurons from amyloid precursor protein knockout mice against Alzheimer's amyloid-beta toxicity and oxidative stress. J. Neurosci. 18(16), 6207-6217.
131. Woodbury, D., Schwarz, E. J., et al. (2000). Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. 61(4), 364-370.
132. Wu, S., Suzuki, Y., et al. (2002). New method for transplantation of neurosphere cells into injured spinal cord through cerebrospinal fluid in rat. Neurosci. Lett. 318(2), 81-84.
133. Xu, J., Kao, S. Y., et al. (2002). Dopamine-dependent neurotoxicity of alpha-synuclein: A mechanism for selective neurodegeneration in Parkinson disease. Nat. Med. 8(6), 600-606.
134. Yan, J., Studer, L., et al. (2001). Ascorbic acid increases the yield of dopaminergic neurons derived from basic fibroblast growth factor expanded mesencephalic precursors. J. Neurochem. 76(1), 307-311.
135. Yang, X., Handler, M., et al. (2000). Role of presenilin-1 in murine neural development. Ann. N. Y. Acad. Sci. 920(10), 165-170.
136. Yi, M., Wu, P., et al. (1999). Evidence that the Igkappa gene MAR regulates the probability of premature V-J joining and somatic hypermutation. J. Immunol. 162, 6029-6039.
137. Ying, Q. L., Nichols, J., et al. (2002). Changing potency by spontaneous fusion. Nature 416(6880), 545-548.